Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tips for Talking to Your Patients About Vaccination

Keri Losavio  |  Issue: May 2021  |  May 13, 2021

Tang Yan Song / shutterstock.com

Tang Yan Song / shutterstock.com

We know a large percentage of the U.S. population falls into a vaccine-hesitant group. In fact, only 60% of Americans plan to be vaccinated against COVID-19, according to an article in The Atlantic.1 Given that rheumatology patients are among the vulnerable, we asked a handful of ACR/ARP members whether they have been vaccinated themselves and how they are broaching the topic with their patients.

Below are some tips to help get the conversation about vaccination started with your patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Acknowledge Concerns

Suleman Bhana, MD, FACR, chair of the ACR’s Communications and Marketing Committee and a rheumatologist in practice at Crystal Run Healthcare, West Nyack, N.Y., says, “I have been vaccinated, along with my adult family members.”

Dr. Bhana says he is recommending all his patients get vaccinated. “I ask them the following questions during a visit: 1) Did you get your COVID-19 vaccine yet? 2) Do you have an appointment or plan to get it? 3) Do you have any concerns about that vaccine that I can help answer?

Dr. Bhana

“I tell them that a national organization has convened a group of physician scientists to give guidelines and recommendations, and I paraphrase the ACR position statement, indicating that all patients with rheumatic and musculoskeletal diseases should receive COVID-19 vaccination, including those on immunomodulatory therapy.2

“I then go over any questions they may have about medication management.

“I find it best to acknowledge their concerns within reason. In the rare event I have a patient who states, ‘There are micro­chips in the vaccine,’ that ends the conversation for me.”

Talk to Every Patient

Dr. Monga

“The great news is that a majority of my patients are already vaccinated at Houston Methodist,” says Kanika Monga, MD. Dr. Monga completed her internship and residency training at the University of Texas Health Sciences Center, Houston, where she also performed a fellowship in rheumatology. She is a rheumatologist at Houston Methodist Academic Medicine Associates.

“I broach the topic with every patient I see in my clinic,” says Dr. Monga. “I respect that each patient is different and may be on different levels of understanding of what is safe and available for them. I reassure them that we have excellent guidance from the ACR, especially when it comes to specific DMARDs/biologics.

“We go through some of the charts together. I remind them that, at the end of the day, their personal choice matters most, but I am available to help dispel myths and acknowledge concerns they may have. I also add that my own family has gotten vaccinated as well.

“As a pregnant patient myself,” continues Dr. Monga, “I understand the importance of getting vaccinated to protect me, the community and my baby. My obstetrician strongly recommends vaccination because she believes pregnant patients are more likely to get a COVID-related illness if they are exposed to the virus.”

The Science Supports Vaccination

Dr. Arabelovic

“Based on the data up until now, the vaccine is of great benefit to protect against COVID-19,” says Senada Arabelovic, DO, Brigham and Women’s Hospital, Boston. “The vaccine has shown to be effective and safe.”

Mr. Richardson

Mr. Richardson

Bob Richardson, PT, FAPTA, agrees. “I believe science supports the positive effects of vaccination,” he says. Mr. Richardson is a practicing physical therapist at Maria Parham Medical Center, a Duke Lifepoint hospital, located in Henderson, N.C. He says a high percentage of his patients are seniors and the hospital is a rural facility. “In this area, I see very few patients and friends who refuse vaccination,” he says.

“I do recommend to my patients that they take the vaccine,” says Mr. Richardson, “and I share with them that I have done so, and I explain that the side effects have proved to be minimal.

“I have always believed in vaccinations, for example, polio. I took the first generation of Dr. [Jonas] Salk’s polio vaccination and, subsequently, influenza vaccines.”

Protect Your Family, Too

“Getting vaccinated yourself may also protect people around you,” says Dr. Arabelovic.

That’s an aspect Sean Fahey, MD, a rheumatologist in practice at Piedmont Healthcare, Mooresville, N.C., emphasizes to his patients: “I point out the benefit of vaccination beyond the individual receiving the vaccine—to other patients, family members and society. We are moving to a new normal.

“I recommend all patients get vaccinated. I typically present the balance between risk and benefit of the choices as a way to frame the discussion. We know the risk of COVID is variable, but there is potential long-term morbidity, as well as a low, but real, chance of death, especially in patients with multiple risk factors. The risk associated with vaccination is lower than the risk of COVID-19.

“I have received my two doses of mRNA vaccine. My choice was driven by several factors: putting my money where my mouth is, setting a good example for my office staff and patients, and protecting my family—including my octogenarian parents who live with me.”

Target Your Conversation

Mohammad A. Ursani, MD, FACP, RhMSUS

Dr. Ursani

“I am recommending all my patients get the vaccine—except for those who have had a prior, severe anaphylactic response to a vaccination or those patients who have previously developed a neurologic condition, such as Guillain-Barré syndrome or transverse myelitis post vaccination,” says Mohammad A. Ursani, MD, RhMSUS. “Further, I have a long discussion on the risks vs. benefits in patients who are currently pregnant or breastfeeding, and make sure to emphasize the data in this population suggests the vaccine is safe for the fetus or child.”

Dr. Ursani is a private practice rheuma­tologist in The Woodlands, Texas, and serves as an adjunct faculty member for the University of Texas, Houston, Internal Medicine Residency Program. He also serves as a volunteer for the ACR and is an ambassador for the Young Physicians Organization for the Harris County Medical Society.

In broaching the topic with his vaccine-hesitant patients, Dr. Ursani says, “I attempt to understand why individuals are hesitant to receive the vaccine and address their questions and/or misconceptions directly. I attempt to demystify the misinformation that is often quoted by providing sound sources with statistical data. I review the benefits of getting vaccinated vs. the risk of not getting it.

“From what I have learned,” he continues, “most people who are initially hesitant, once provided with sound, unbiased data with confidence, are more likely to be at ease with receiving the vaccine. If the individual still refuses, I am sure to bring it up at their next clinic visit after providing sources for them to read over and contemplate.”

Dr. Ursani was vaccinated as soon as it became available for healthcare personnel in his area. “I have seen firsthand how severe COVID-19 infection can be, even in individuals who may not have any comorbidities or risk factors. I have reviewed the efficacy and safety data in the vaccine trials and have no doubt that it is beneficial for me and my family.

“As a physician, I believe in science, and I hope to act as a role model and influence my community members and patients to do the same.”


Keri Losavio is the staff editor of The Rheumatologist, a position she has held since 2014.

Watch: Building Vaccine Confidence in Rheumatic Disease Patients

This virtual town hall, held May 13, addressed the reasons some rheumatic disease patients, including those in communities of color and underserved communities, are hesitant to take the COVID-19 vaccine. The discussion included best practices, resources, and talking points that rheumatology providers can use to provide information to their patients.

References

  1. Engber D. America is now in the hands of the vaccine-hesitant. The Atlantic. 2021 Mar 22.
  2. The ACR COVID-19 Vaccine Clinical Guidance Task Force. COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases. American College of Rheumatology. 2021 Mar 4.

ACR Guidance Statement: Recommendations for Use of the COVID-19 Vaccine in Patients with Rheumatic & Musculoskeletal Disease2

Guidance StatementLevel of Task Force Consensus
RMD and AIIRD patients should receive COVID-19 vaccination, consistent with the age restriction of the EUA and/or FDA approval.*Moderate
RMD patients without an AIIRD who are on immunomodulatory therapy should be vaccinated in a similar fashion as described in this guidance for AIIRD patients receiving those same treatments.Moderate
Based on the data for the mRNA COVID-19 vaccines available in the U.S., there is no preference for one COVID-19 vaccine over another. Therefore, AIIRD patients should receive either vaccine available to them.Moderate
For a multi-dose vaccine, AIIRD patients should receive the second dose of the same vaccine, even if there are non-serious adverse events associated with receipt of the first dose, consistent with timing described in CDC guidelines.Strong
Healthcare providers should not routinely order any lab testing (e.g., antibody tests for IgM and/or IgG to spike or nucleocapsid proteins) to assess immunity to COVID-19 post-vaccination, nor to assess the need for vaccination in a yet-unvaccinated person.Strong
Following COVID-19 vaccination, RMD patients should continue to follow all public health guidelines regarding physical distancing and other preventive measures.Strong
Household members and other frequent, close contacts of AIIRD patients should undergo COVID-19 vaccination when available to them to facilitate a cocooning effect that may help protect the AIIRD patient. No priority for early vaccination is recommended for household members.Moderate
While vaccination would ideally occur in the setting of well-controlled AIIRD, except for those patients with life-threatening illness (e.g.,in the ICU for any reason), COVID vaccination should occur as soon as possible for those for whom it is being recommended, irrespective of disease activity and severity.Strong-Moderate

*age ≥16 as of January 2021
RMD=rheumatic and musculoskeletal disease; AIIRD=autoimmune and inflammatory rheumatic disease; EUA=emergency use authorization; FDA=Food and Drug Administration; mRNA=messenger RNA; CDC=Centers for Disease Control and Prevention; ICU=intensive care unit

Page: 1 2 3 | Multi-Page
Share: 

Filed under:Patient Perspective Tagged with:COVID-19physician-patient communicationvaccination

Related Articles

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Lia Kos / shutterstock.com Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S….

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    Phil Seo, MD, MHS “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

    Adventures in Vaccinating

    April 17, 2021

    I’m a believer in blue light. I’ve spent years lecturing my insomniac patients, buzzed on prednisone, on the importance of good sleep hygiene. In my own home, I try to practice what I preach. When I’m ready for bed, I leave my laptop and phone on my nightstand, and concentrate on relaxing. If I can’t…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences